2021 data FDA MAUDE openFDA FDA Class II

System, Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA Class II (moderate risk, special controls required), regulated under 21 CFR §866.3361 (Microbiology panel).

FDA MAUDE casebook

openFDA event book System LIGHT-BOOK · MAUDE

#946 of 1000 · 431 reports · 2015–2021

  • BOOK 431 reports
  • RANK #946 of 1000
  • DEATH 0 death-typed
  • INJ 10 injury-typed
  • MALF 420 malfunction
  • SPAN 2015–2021
  • PEAK 2019: 107
  • PHOTO Platelet And Plasma S…

Nearest event-volume peer: Platelet And Plasma Separator For Bone Graft Handling (1 report gap)

System, Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates sits #946 of 1000 among tracked device types with 431 MAUDE reports spanning 2015–2021. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Similar-volume device →

Malfunction reports run above the device-type norm

System carries 97.4% MALFUNCTION-coded reports, 32.6pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
  • INJ 2.3% corpus 30.3% · below corpus mean (-28.0 pp)
  • MALF 97.4% corpus 64.8% · above corpus mean (+32.6 pp)

Lead product-problem code Incorrect, Inadequate or Imprecise Result or Readings is 64% of coded problems · Top event location I is 100% of location-tagged rows .

System in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows System, Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates carries 431 MAUDE reports, ranked #946 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 420 (97.4%)
Injury 10 (2.3%)
1 (0.2%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

418 (97.0%)
Required Intervention 9 (2.1%)
Disability 2 (0.5%)
Hospitalization 2 (0.5%)

Top Product Problems

Incorrect, Inadequate or Imprecise Result or Readings 284
Incorrect Or Inadequate Test Results 130
Grounding Malfunction 5
Protective Measures Problem 5
Device Operates Differently Than Expected 2
Improper or Incorrect Procedure or Method 2
Output Problem 2
Appropriate Device Problem Term/Code Not Available 1
Charred 1
Data Problem 1
False Device Output 1
Insufficient Device Problem Information 1
Missing Test Results 1
Overheating of Device 1
Patient Data Problem 1
Smoking 1
Sparking 1
Thermal Decomposition of Device 1

Yearly Trend

15
2015: 23
16
2016: 48
17
2017: 94
18
2018: 66
19
2019: 107
20
2020: 89
21
2021: 4

Reports in 2020 (89) held close to the prior two-year average of 87.

Related Entities for System, Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates

Event Locations

I 430 (99.8%)
1 (0.2%)

Nationwide devices with a comparable report-volume footprint

System carries zero death-typed MAUDE reports, so the peer set below compares report volume only; both axes are floored at ≥100 reports so the neighborhood stays in the advertised mass.

Disclaimer: MAUDE figures for System are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for System; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.